SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 48 filers reported holding SCPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $411,000 | -39.6% | 81,891 | -19.9% | 0.00% | -40.0% |
| Q3 2021 | $680,000 | -19.7% | 102,207 | -26.3% | 0.01% | -16.7% |
| Q2 2021 | $847,000 | -9.6% | 138,604 | -1.7% | 0.01% | -14.3% |
| Q1 2021 | $937,000 | +579.0% | 140,967 | +438.8% | 0.01% | +600.0% |
| Q4 2020 | $138,000 | +36.6% | 26,164 | +47.1% | 0.00% | 0.0% |
| Q4 2019 | $101,000 | +17.4% | 17,791 | +21.6% | 0.00% | 0.0% |
| Q3 2019 | $86,000 | -27.1% | 14,634 | -60.4% | 0.00% | -50.0% |
| Q2 2019 | $118,000 | +66.2% | 36,921 | +55.8% | 0.00% | +100.0% |
| Q1 2019 | $71,000 | – | 23,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,857,143 | $35,429,000 | 2.71% |
| Orbimed Advisors | 3,409,865 | $42,282,000 | 0.52% |
| AWM Investment Company, Inc. | 213,317 | $2,645,000 | 0.51% |
| DAFNA Capital Management LLC | 55,844 | $692,000 | 0.34% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 40,373 | $501,000 | 0.07% |
| Alyeska Investment Group, L.P. | 223,438 | $2,771,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,330 | $302,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 69,500 | $862,000 | 0.01% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 36,206 | $449,000 | 0.00% |
| PEDDOCK CAPITAL ADVISORS, LLC | 100 | $1,000 | 0.00% |